Etanercept in Hidradenitis Suppurativa

Update Il y a 4 ans
Reference: NCT00329823

Woman and Man

  • | Country :
  • Greece
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The rationale of the protocol is based on the reported beneficiary results of case-patients by the administration of other anti-TNF drug (infliximab) in separate cases on the grounds of a probable autoimmune predisposition of the disease. The objective of this study is to clarify the potency of etanercept for the therapy of hidradenitis suppurativa.


Inclusion criteria

  • Hidradenitis Suppurativa

Links